Validation of Syndromic Surveillance for Respiratory Pathogen Activity

Syndromic surveillance is increasingly used to signal unusual illness events. To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity. These syndromes showed higher...

Full description

Bibliographic Details
Main Authors: Cees van den Wijngaard, Liselotte van Asten, Wilfrid van Pelt, Nico J.D. Nagelkerke, Robert Verheij, Albert J. de Neeling, Arnold Dekkers, Marianne A.B. van der Sande, Hans van Vliet, Marion P.G. Koopmans
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2008-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/14/6/07-1467_article
id doaj-67e1be04e81d41a588d47dd32cc1762b
record_format Article
spelling doaj-67e1be04e81d41a588d47dd32cc1762b2020-11-24T21:51:03ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592008-06-0114691792510.3201/eid1406.071467Validation of Syndromic Surveillance for Respiratory Pathogen ActivityCees van den WijngaardLiselotte van AstenWilfrid van PeltNico J.D. NagelkerkeRobert VerheijAlbert J. de NeelingArnold DekkersMarianne A.B. van der SandeHans van VlietMarion P.G. KoopmansSyndromic surveillance is increasingly used to signal unusual illness events. To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity. These syndromes showed higher levels in winter, which corresponded with higher laboratory counts of Streptococcus pneumoniae, respiratory syncytial virus, and influenza virus. Multiple linear regression models indicated that most syndrome variations (up to 86%) can be explained by counts of respiratory pathogens. Absenteeism and pharmacy syndromes might reflect nonrespiratory conditions as well. We also observed systematic syndrome elevations in the fall, which were unexplained by pathogen counts but likely reflected rhinovirus activity. Earliest syndrome elevations were observed in absenteeism data, followed by hospital data (+1 week), pharmacy/general practitioner consultations (+2 weeks), and deaths/laboratory submissions (test requests) (+3 weeks). We conclude that these syndromes can be used for respiratory syndromic surveillance, since they reflect patterns in respiratory pathogen activity.https://wwwnc.cdc.gov/eid/article/14/6/07-1467_articlerespiratory tract infectionsepidemiology syndromepopulation surveillancedisease outbreakshumansresearch
collection DOAJ
language English
format Article
sources DOAJ
author Cees van den Wijngaard
Liselotte van Asten
Wilfrid van Pelt
Nico J.D. Nagelkerke
Robert Verheij
Albert J. de Neeling
Arnold Dekkers
Marianne A.B. van der Sande
Hans van Vliet
Marion P.G. Koopmans
spellingShingle Cees van den Wijngaard
Liselotte van Asten
Wilfrid van Pelt
Nico J.D. Nagelkerke
Robert Verheij
Albert J. de Neeling
Arnold Dekkers
Marianne A.B. van der Sande
Hans van Vliet
Marion P.G. Koopmans
Validation of Syndromic Surveillance for Respiratory Pathogen Activity
Emerging Infectious Diseases
respiratory tract infections
epidemiology syndrome
population surveillance
disease outbreaks
humans
research
author_facet Cees van den Wijngaard
Liselotte van Asten
Wilfrid van Pelt
Nico J.D. Nagelkerke
Robert Verheij
Albert J. de Neeling
Arnold Dekkers
Marianne A.B. van der Sande
Hans van Vliet
Marion P.G. Koopmans
author_sort Cees van den Wijngaard
title Validation of Syndromic Surveillance for Respiratory Pathogen Activity
title_short Validation of Syndromic Surveillance for Respiratory Pathogen Activity
title_full Validation of Syndromic Surveillance for Respiratory Pathogen Activity
title_fullStr Validation of Syndromic Surveillance for Respiratory Pathogen Activity
title_full_unstemmed Validation of Syndromic Surveillance for Respiratory Pathogen Activity
title_sort validation of syndromic surveillance for respiratory pathogen activity
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2008-06-01
description Syndromic surveillance is increasingly used to signal unusual illness events. To validate data-source selection, we retrospectively investigated the extent to which 6 respiratory syndromes (based on different medical registries) reflected respiratory pathogen activity. These syndromes showed higher levels in winter, which corresponded with higher laboratory counts of Streptococcus pneumoniae, respiratory syncytial virus, and influenza virus. Multiple linear regression models indicated that most syndrome variations (up to 86%) can be explained by counts of respiratory pathogens. Absenteeism and pharmacy syndromes might reflect nonrespiratory conditions as well. We also observed systematic syndrome elevations in the fall, which were unexplained by pathogen counts but likely reflected rhinovirus activity. Earliest syndrome elevations were observed in absenteeism data, followed by hospital data (+1 week), pharmacy/general practitioner consultations (+2 weeks), and deaths/laboratory submissions (test requests) (+3 weeks). We conclude that these syndromes can be used for respiratory syndromic surveillance, since they reflect patterns in respiratory pathogen activity.
topic respiratory tract infections
epidemiology syndrome
population surveillance
disease outbreaks
humans
research
url https://wwwnc.cdc.gov/eid/article/14/6/07-1467_article
work_keys_str_mv AT ceesvandenwijngaard validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT liselottevanasten validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT wilfridvanpelt validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT nicojdnagelkerke validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT robertverheij validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT albertjdeneeling validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT arnolddekkers validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT marianneabvandersande validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT hansvanvliet validationofsyndromicsurveillanceforrespiratorypathogenactivity
AT marionpgkoopmans validationofsyndromicsurveillanceforrespiratorypathogenactivity
_version_ 1725880833183580160